Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPS immunization to identify pre-erythrocytic malaria antigens
NL-OMON40673Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2014
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of chloroquine and Plasmodium falciparum sporozoites in malaria (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Generation of B-cells for delineation of antibody responses. Started Oct 2014; status: active, not recruiting.
02
Drugs
chloroquinePlasmodium falciparum sporozoites
03
Conditions
malaria
Beyond the preview
Go deeper on NL-OMON40673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40673.